Vertex Pharmaceuticals | VRTX - Market Capitalization


Vertex Pharmaceuticals reported $142.88B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amgen USD 195.44B 5.55B Jun/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Biogen USD 33.38B 1.48B Sep/2026
BioMarin Pharmaceutical USD 11.1B 516M Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
Insmed USD 24.93B 1.82B Sep/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 653.61B 42.25B Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Neurocrine Biosciences USD 14.5B 86M Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
Vertex Pharmaceuticals USD 143.16B 10.65B Nov/2026